Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
10.67
Dollar change
+0.73
Percentage change
7.34
%
IndexRUT P/E- EPS (ttm)-1.44 Insider Own50.59% Shs Outstand191.02M Perf Week33.54%
Market Cap2.29B Forward P/E- EPS next Y-1.11 Insider Trans5.22% Shs Float105.94M Perf Month78.43%
Income-275.58M PEG- EPS next Q-0.38 Inst Own41.66% Short Float20.84% Perf Quarter151.65%
Sales0.00M P/S- EPS this Y14.99% Inst Trans1.65% Short Ratio6.68 Perf Half Y92.95%
Book/sh1.86 P/B5.75 EPS next Y27.80% ROA-36.03% Short Interest22.08M Perf Year188.38%
Cash/sh1.27 P/C8.40 EPS next 5Y- ROE-59.15% 52W Range2.74 - 10.00 Perf YTD161.52%
Dividend Est.- P/FCF- EPS past 5Y-112.10% ROI-61.35% 52W High6.70% Beta1.58
Dividend TTM- Quick Ratio4.19 Sales past 5Y0.00% Gross Margin- 52W Low288.71% ATR (14)0.75
Dividend Ex-Date- Current Ratio4.19 EPS Y/Y TTM10.44% Oper. Margin0.00% RSI (14)81.42 Volatility10.01% 9.67%
Employees421 Debt/Eq0.26 Sales Y/Y TTM- Profit Margin- Recom1.57 Target Price9.33
Option/ShortYes / Yes LT Debt/Eq0.23 EPS Q/Q101.09% Payout- Rel Volume1.01 Prev Close9.94
Sales Surprise- EPS Surprise100.00% Sales Q/Q- EarningsNov 08 AMC Avg Volume3.31M Price10.67
SMA2050.66% SMA5082.20% SMA200104.72% Trades Volume3,346,181 Change7.34%
Date Action Analyst Rating Change Price Target Change
Jan-16-24Upgrade H.C. Wainwright Neutral → Buy $12
Sep-25-23Initiated JMP Securities Mkt Outperform $9
Sep-05-23Initiated Citigroup Buy $8
Aug-14-23Initiated TD Cowen Market Perform
May-02-23Initiated H.C. Wainwright Neutral
Mar-01-21Initiated Morgan Stanley Overweight $40
Mar-01-21Initiated JP Morgan Neutral $35
Mar-01-21Initiated Goldman Neutral $40
Mar-01-21Initiated BofA Securities Buy $45
Today 04:05PM
Feb-13-24 04:05PM
Feb-12-24 04:05PM
Feb-08-24 01:22AM
Feb-07-24 04:01PM
11:02AM Loading…
Jan-27-24 11:02AM
Jan-18-24 12:00PM
10:24AM
Jan-09-24 08:44AM
Jan-08-24 06:30AM
06:30AM
Jan-05-24 09:00AM
Jan-03-24 04:05PM
Dec-19-23 09:01AM
Dec-11-23 09:00AM
04:05PM Loading…
Dec-01-23 04:05PM
Nov-27-23 07:01PM
Nov-21-23 09:00AM
06:00AM
Nov-17-23 09:00AM
Nov-09-23 04:05PM
Nov-08-23 04:05PM
Nov-02-23 09:05AM
Nov-01-23 10:30AM
Oct-19-23 10:30AM
Oct-10-23 04:15PM
Oct-02-23 07:00AM
Sep-27-23 08:31AM
Sep-11-23 06:30AM
Aug-30-23 04:05PM
09:00AM Loading…
Aug-29-23 09:00AM
Aug-03-23 05:03PM
04:05PM
Jun-16-23 09:00AM
May-31-23 04:05PM
May-22-23 07:33AM
May-16-23 06:00AM
May-08-23 04:35PM
04:26PM
04:05PM
May-04-23 01:56PM
May-03-23 04:05PM
09:55AM
May-02-23 04:30PM
12:50PM
Apr-24-23 04:05PM
Apr-20-23 10:07AM
Apr-19-23 04:05PM
Apr-17-23 09:55AM
06:17AM
Apr-14-23 10:27AM
Apr-13-23 09:00AM
Apr-12-23 04:05PM
Apr-10-23 04:05PM
Mar-24-23 03:20PM
Mar-16-23 04:05PM
Mar-14-23 04:53PM
Mar-01-23 04:05PM
Feb-10-23 08:18AM
Feb-02-23 04:05PM
Jan-26-23 04:05PM
Jan-03-23 04:05PM
Dec-11-22 05:30PM
Dec-01-22 12:11AM
Nov-30-22 10:55AM
08:43AM
Nov-29-22 04:05PM
Nov-17-22 01:58PM
Nov-14-22 04:05PM
Nov-03-22 09:07AM
Nov-02-22 04:05PM
Oct-18-22 07:43AM
Sep-09-22 04:05PM
Sep-03-22 08:39AM
Aug-09-22 11:54AM
Aug-04-22 04:05PM
Jun-17-22 09:00AM
Jun-13-22 04:05PM
Jun-07-22 04:05PM
Jun-02-22 01:55AM
Jun-01-22 04:05PM
May-12-22 05:40PM
May-11-22 07:19AM
May-10-22 04:05PM
May-04-22 04:05PM
May-02-22 04:35PM
Mar-24-22 04:12PM
Mar-20-22 08:02AM
Mar-16-22 08:30AM
Mar-09-22 04:05PM
Mar-08-22 04:35PM
Feb-28-22 09:00AM
Feb-17-22 04:38PM
Feb-15-22 10:05AM
Jan-27-22 06:23PM
Jan-11-22 06:56AM
06:00AM
Jan-10-22 04:30PM
Jan-04-22 04:05PM
Dec-17-21 08:00AM
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NELSEN ROBERTDirectorFeb 08Buy5.501,818,1819,999,99612,446,022Feb 12 05:46 PM
CRANDELL KEITH10% OwnerFeb 08Buy5.501,818,1819,999,99612,446,022Feb 12 05:43 PM
ARCH Venture Fund X, L.P.10% OwnerFeb 08Buy5.501,818,1819,999,99612,446,022Feb 12 05:43 PM
Hordo ChristianEVP, Chief Business OfficerDec 15Sale4.0075,000300,098867,455Dec 18 04:51 PM
Flagship Ventures Fund V Gener10% OwnerJun 07Sale6.24200,0001,247,9401,380,277Jun 08 07:00 PM
Flagship Ventures Fund V Gener10% OwnerJun 06Sale6.31203,7581,284,9181,403,037Jun 08 07:00 PM
Flagship Ventures Fund V Gener10% OwnerMay 26Sale6.2382,000510,5731,425,334May 26 08:00 PM
Flagship Ventures Fund V Gener10% OwnerMay 25Sale6.35115,372732,8661,434,664May 26 08:00 PM
Flagship Ventures Fund V Gener10% OwnerMay 24Sale6.57347,8702,283,8361,447,791May 26 08:00 PM